FDA Whistleblower Blasts New Merck Painkiller

By Erin Marie Daly (September 13, 2006, 12:00 AM EDT) -- The same U.S. Food and Drug Administrator that railed against the agency's actions during the rise and fall of Merck & Co. Inc.'s blockbuster arthritis drug Vioxx made headlines again on Wednesday when he criticized the drug company's experimental painkiller, Arcoxia, saying it may carry the same risk of heart attacks and strokes as Vioxx....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!